|
COMPANY OVERVIEW
We are a product focused specialty pharmaceutical
company that has developed three proprietary platforms,
two of which now include FDA approved products. Our
products typically improve safety and efficacy profiles
by minimizing dosing and reducing side effects while
improving patient compliance.
History
Antares was formed in 2001 when Medi-Ject Corporation (a
device company) merged with Permatec Holding AG (a
developer of transdermal delivery systems). In the late
1970’s Medi-Ject was one of the first companies to
develop reusable needle-free injection devices. Since
that time costs have decreased and the technology has
gained acceptance. Presently we have broad approval for
our device in the US for insulin and in Europe, Asia and
elsewhere for human growth hormone. In addition, we have
a disposable pressure assisted auto injector product
which uses a disposable single use small gauge needle
for unit dose injectable drugs. And we have recently
added a disposable multi-use pen injector.
Operations
Antares operates in three locations:
| Ewing, New Jersey |
|
Corporate Offices |
| Minneapolis, Minnesota |
|
Device Division |
| Basel, Switzerland |
|
European Offices |
|
